Attachment 6.4 - Participant Per Test Fees 05052025.docx

Attachment 6.4 is a document detailing participant per test fees for a drug testing contract covering Fiscal Years 2026 and 2027 (July 1, 2025, through June 30, 2027). The document outlines eight different types of drug screening tests including standard 6-Panel Urine Drug Screens (UDS), standard tests with Ethyl Glucuronide (ETG), comprehensive tests, and various combinations involving ketamine and ETG screening. The contract period spans two fiscal years, with all testing costs to be directly borne by participants.

The pricing document includes placeholders for specific fee amounts for each test type, indicating that final pricing has not yet been finalized. The tests range from basic 6-panel screenings to more complex comprehensive screenings that include additional substances like ketamine and ETG. A breathalyzer test and a hair, fingernail, and/or toenail comprehensive test with ketamine and ETG are also included in the testing options. The document suggests this is part of a broader drug testing program, likely for a government agency, treatment program, or workforce monitoring initiative, with standardized testing protocols and pricing structure for the specified two-year period.